Conrad Tou

943 total citations
11 papers, 683 citations indexed

About

Conrad Tou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Conrad Tou has authored 11 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Conrad Tou's work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Blood Pressure and Hypertension Studies (2 papers). Conrad Tou is often cited by papers focused on Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Blood Pressure and Hypertension Studies (2 papers). Conrad Tou collaborates with scholars based in United States, Sweden and China. Conrad Tou's co-authors include June Zhao, Ingrid Gause‐Nilsson, Chang Yu Pan, Wenying Yang, John S. Holcenberg, Erin Morris, Elizabeth Harvey, Raymond J. Hutchinson, Mitchell S. Cairo and F. Leonard Johnson and has published in prestigious journals such as Blood, Diabetes Research and Clinical Practice and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Conrad Tou

11 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Conrad Tou United States	10	301	281	241	208	110	11	683
Francesco Trevisani Italy	12	255 0.8×	92 0.3×	311 1.3×	81 0.4×	99 0.9×	64	760
Cemal Nuri Erçin Türkiye	18	162 0.5×	243 0.9×	50 0.2×	92 0.4×	59 0.5×	37	885
Kotaro Haruhara Japan	16	151 0.5×	111 0.4×	119 0.5×	182 0.9×	23 0.2×	73	696
Antonio Nicolucci Italy	11	321 1.1×	289 1.0×	58 0.2×	27 0.1×	215 2.0×	16	881
Augusto Antonello Italy	14	208 0.7×	95 0.3×	160 0.7×	69 0.3×	15 0.1×	41	679
Nicholas R. Loon United States	10	203 0.7×	158 0.6×	276 1.1×	48 0.2×	158 1.4×	14	931
Nikhil Kamat United States	8	102 0.3×	131 0.5×	75 0.3×	38 0.2×	60 0.5×	22	541
Isabella Bruzzi Italy	13	146 0.5×	92 0.3×	139 0.6×	88 0.4×	45 0.4×	13	988
Lyubov Chaykovska Switzerland	14	101 0.3×	172 0.6×	182 0.8×	21 0.1×	84 0.8×	33	658
Christian Demers Canada	10	62 0.2×	130 0.5×	46 0.2×	137 0.7×	149 1.4×	10	645

Countries citing papers authored by Conrad Tou

Since Specialization

Citations

This map shows the geographic impact of Conrad Tou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad Tou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad Tou more than expected).

Fields of papers citing papers by Conrad Tou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad Tou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad Tou. The network helps show where Conrad Tou may publish in the future.

Co-authorship network of co-authors of Conrad Tou

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad Tou. A scholar is included among the top collaborators of Conrad Tou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad Tou. Conrad Tou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Tsao, Yeou‐Ping, Conrad Tou, Frank Lee, et al.. (2021). Topical BRM421 Ophthalmic Solution improves signs and symptoms of moderate to severe dry eye patients in clinical trials. 62(8). 1335–1335. 1 indexed citations

KUMAR, K.M. PRASANNA, et al.. (2014). Saxagliptin as initial therapy in treatment-naive Indian adults with type 2 diabetes mellitus inadequately controlled with diet and exercise alone: a randomized, double-blind, placebo-controlled, phase IIIb clinical study. International Journal of Diabetes in Developing Countries. 34(4). 201–209. 13 indexed citations

Li, Haiyan, et al.. (2012). Pharmacokinetic Study of Saxagliptin in Healthy Chinese Subjects. Clinical Drug Investigation. 32(7). 465–473. 11 indexed citations

Carlson, Glenn, Conrad Tou, Shamik Parikh, Bruce K. Birmingham, & Kathleen Butler. (2011). Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study. Diabetes Therapy. 2(3). 123–132. 32 indexed citations

Yang, Wenying, Chang Yu Pan, Conrad Tou, June Zhao, & Ingrid Gause‐Nilsson. (2011). Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial. Diabetes Research and Clinical Practice. 94(2). 217–224. 88 indexed citations

Pan, Chang Yu, Wenying Yang, Conrad Tou, Ingrid Gause‐Nilsson, & June Zhao. (2011). Efficacy and safety of saxagliptin in drug‐naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial. Diabetes/Metabolism Research and Reviews. 28(3). 268–275. 70 indexed citations

Ratner, Robert E., Shamik Parikh, & Conrad Tou. (2007). Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes. Diabetes and Vascular Disease Research. 4(3). 214–221. 37 indexed citations

Goldstein, Barry J., Julio Rosenstock, Deborah Anzalone, Conrad Tou, & K. Peter Öhman. (2006). Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12‐week dose-ranging trial. Current Medical Research and Opinion. 22(12). 2575–2590. 56 indexed citations

Izzo, Joseph L., et al.. (2004). Antihypertensive Efficacy of Candesartan‐Lisinopril in Combination vs. Up‐Titration of Lisinopril: The AMAZE Trials. Journal of Clinical Hypertension. 6(9). 485–493. 25 indexed citations

10.

Trachtman, Howard, Rachel Frank, John D. Mahan, et al.. (2003). Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatric Nephrology. 18(6). 548–553. 49 indexed citations

11.

Goldman, Stanton, John S. Holcenberg, Jerry Z. Finklestein, et al.. (2001). A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 97(10). 2998–3003. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact